Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Authors
Keywords
Amyloid-PET, [<sup>18</sup>F]FDG PET, Preclinical Alzheimer’s disease, Phosphorylated tau
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 45, Issue 6, Pages 1021-1030
Publisher
Springer Nature
Online
2018-02-02
DOI
10.1007/s00259-018-3933-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage
- (2017) Silvia Morbelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline
- (2017) Nare Torosyan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Why has therapy development for dementia failed in the last two decades?
- (2016) Serge Gauthier et al. Alzheimers & Dementia
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease
- (2016) T A Pascoal et al. MOLECULAR PSYCHIATRY
- VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis
- (2016) Sulantha Mathotaarachchi et al. Frontiers in Neuroinformatics
- Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
- (2015) Sylvia Villeneuve et al. BRAIN
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Association of hypometabolism and amyloid levels in aging, normal subjects
- (2014) V. J. Lowe et al. NEUROLOGY
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
- (2013) A. Brück et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
- (2012) A. D. Joshi et al. JOURNAL OF NUCLEAR MEDICINE
- Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative
- (2012) Joshua D. Grill et al. NEUROBIOLOGY OF AGING
- Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
- (2012) Dominic Holland et al. PLoS One
- Tau pathology in children and young adults: can you still be unconditionally baptist?
- (2011) Charles Duyckaerts ACTA NEUROPATHOLOGICA
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- BEaST: Brain extraction based on nonlocal segmentation technique
- (2011) Simon F. Eskildsen et al. NEUROIMAGE
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease
- (2009) Marine Fouquet et al. BRAIN
- Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection
- (2009) Kelvin K. Leung et al. NEUROIMAGE
- Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease
- (2008) L. Mosconi et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now